Single infusion of zoledronic acid 5mg provides sustained benefits in bone mineral density and biomarkers at 12 months in postmenopausal women with low bone mineral density and prior alendronate therapy

✍ Scribed by McClung, Michael; Omizo, Molly; Minkoff, Jerome; Fiske, Darrell; Kriegman, Audrey; Beamer, Emily; Zhou, Wenchun

• Book ID: 121986715
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 80 KB
• Volume: 10
• Category: Article
• ISSN: 1094-6950
• DOI: 10.1016/j.jocd.2007.03.082